CSPG5

CSPG5 (neuroglycan C/CALEB) is a brain-specific transmembrane chondroitin sulfate proteoglycan that promotes dendritic arborization and spine morphogenesis through its EGF-like domain, activating Rac1 at the plasma membrane via a PI3K-Akt-mTOR/PKC-dependent signaling pathway for branching and a PKC-dependent but PI3K-independent pathway for spine formation (PMID:17431398, PMID:27412363). Its cytoplasmic tail binds the Golgi-associated protein PIST to regulate intracellular trafficking, and recruits the PP2A holoenzyme via the B56beta subunit, which suppresses Akt phosphorylation and thereby limits dendritic branching (PMID:12885772, PMID:18385213). In the cerebellum, CSPG5 is required for presynaptic maturation of GABAergic synapses and proper timing of climbing fiber synapse elimination on Purkinje cells, with its chondroitin sulfate modification dynamically regulated during postnatal development (PMID:23889129).

1. 1998 Medium

   Molecular cloning established CSPG5 as a novel brain-specific transmembrane chondroitin sulfate proteoglycan with a defined domain architecture including an EGF-like domain and cytoplasmic tail, providing the structural framework for all subsequent functional studies.

   Evidence cDNA cloning, Northern blot, and sequence analysis of human NGC

   PMID:9950058

   Open questions at the time

   • Single-lab characterization without independent replication
   • Protein-level validation of glycosaminoglycan attachment not performed
   • Function of individual domains unknown
2. 2003 High

   Identification of the PIST interaction via the cytoplasmic juxtamembrane region revealed a Golgi-based trafficking mechanism that controls delivery of CSPG5 to the cell surface, establishing that the cytoplasmic tail is a regulatory hub.

   Evidence Yeast two-hybrid, reciprocal co-immunoprecipitation, co-localization in COS7 cells and hippocampal neurons with brefeldin A/nocodazole perturbation

   PMID:12885772

   Open questions at the time

   • Functional consequence of disrupting PIST binding on neuronal morphology not tested
   • Whether PIST interaction regulates chondroitin sulfate modification is unknown
3. 2007 High

   Gain- and loss-of-function experiments demonstrated that CSPG5's EGF-like domain drives both dendritic branching and spine morphogenesis, and pathway dissection revealed a signaling switch — PI3K-Akt-mTOR/PKC for branching versus PKC-only for spine formation — establishing CSPG5 as a bifunctional signaling receptor in dendritogenesis.

   Evidence Overexpression and inactivation in neurons, in utero electroporation in mouse cortex, pharmacological PI3K/mTOR/PKC inhibition

   PMID:17431398

   Open questions at the time

   • Receptor or co-receptor that transduces the EGF-like domain signal not identified
   • Whether PKC acts directly on CSPG5 or indirectly is unknown
4. 2008 High

   Discovery that PP2A, recruited through B56beta binding to the CSPG5 cytoplasmic tail, dephosphorylates Akt and selectively suppresses dendritic branching but not spine formation established a negative-feedback loop that tunes CSPG5 signaling output.

   Evidence Yeast two-hybrid, affinity chromatography with mass spectrometry, co-immunoprecipitation, Akt phosphorylation assay in neurons

   PMID:18385213

   Open questions at the time

   • Specific PP2A substrate site on Akt not mapped
   • Whether B56beta competes with PIST for cytoplasmic tail binding is unknown
5. 2013 High

   A knockout mouse revealed that CSPG5 is required in vivo for presynaptic maturation of cerebellar GABAergic synapses and climbing fiber synapse elimination, and that its chondroitin sulfate modification is developmentally regulated, extending its role beyond dendrite morphogenesis to synapse remodeling.

   Evidence CALEB-deficient mouse, patch-clamp electrophysiology on Purkinje cells, Rota-Rod behavior, Sholl analysis

   PMID:23889129

   Open questions at the time

   • Whether the synapse phenotype depends on the EGF-like domain or the chondroitin sulfate chains is unresolved
   • Cell-autonomy of the presynaptic phenotype not established
   • Molecular partners mediating synapse elimination function unknown
6. 2016 High

   Identification of Rac1 as the small GTPase activated by CSPG5 at the plasma membrane to drive dendritic branching, together with the finding that RhoG antagonizes this by reducing surface CSPG5, resolved the downstream effector step and revealed a Rho-GTPase-level control of CSPG5 surface availability.

   Evidence Rac1 activation assay, gain/loss-of-function with Rac1, RhoG, and Cdc42 isoform-specific constructs in hippocampal neurons

   PMID:27412363

   Open questions at the time

   • GEF that connects CSPG5 to Rac1 activation not identified
   • Mechanism by which RhoG reduces CSPG5 surface levels unknown
   • Whether Rac1 mediates the spine morphogenesis branch in addition to branching is untested

• The extracellular ligand or co-receptor that engages the EGF-like domain to initiate signaling remains unidentified, and the functional significance of the developmental switch from chondroitin sulfate-bearing to non-glycanated CSPG5 isoforms is mechanistically unexplained.
• No extracellular binding partner for the EGF-like domain has been identified
• Structural basis of CSPG5 signaling is unknown
• Role of chondroitin sulfate chains versus the protein core in synapse maturation is unresolved